The Dutch non-profit taking on @abbvie over Humira

The Dutch non-profit taking on @abbvie over Humira. The pharma giant overcharged the Dutch healthcare system for it… https://t.co/o35l1LbxwX

@US_FDA @SpherixInsights @BiosimCenter This aligns

Remember to stop #Humira and seek medical attention if you come down with infection

@Sandoz_Global ‘ HCF Hyrimoz, a biosimilar referencing @abbvie ‘s Humira has been approved by the European Commissi… https://t.co/6AMT4jqeWM

Live vaccines on Monday and then one month until I finally start #adalimumab Hoping that it helps me get into, and… https://t.co/sfHhVa7gRx

$pfe $biib $nvs NEW ARTICLE : Biosimilars expected to save $180B over next five years as more gain approval https://t.co/zkSi4hhIAg

$pfe $biib $nvs NEW ARTICLE : Biosimilars expected to save $180B over next five years as more gain approval https://t.co/zkSi4hhaKI

With 2023 poised to be the year of the #Humira biosimilar wave, @cardinalhealth has issued a new report on market e… https://t.co/0c8es50ARy

34yo w SB #Crohns, Multiple✂️ ➡️ 150cm SB in continuity w colo… https://t.co/6QkFAzoZ4G